Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

LEMVIG BIOGASANLÆG A.M.B.A. Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading...   Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.3% 0.3%   Bankruptcy risk   0.9% 1.1% 1.1% 1.1% 1.0% 1.0% 13.0% 13.0%   Credit score (0-100)   90 86 85 84 87 86 18 18   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   640.7 186.3 416.9 171.9 553.0 493.3 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   15,914 12,802 12,531 12,152 12,992 14,882 0.0 0.0   EBITDA   10,248 7,281 6,852 6,486 6,527 7,937 0.0 0.0   EBIT   674 480 669 565 610 356 0.0 0.0   Pre-tax profit (PTP)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Net earnings   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Pre-tax profit without non-rec. items   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   26,770 25,014 23,026 20,288 16,947 16,135 0.0 0.0   Shareholders equity total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Interest-bearing liabilities   27,640 25,923 24,173 22,391 20,574 18,722 0.0 0.0   Balance sheet total (assets)   56,900 49,896 48,796 47,451 37,935 34,198 0.0 0.0   Net Debt   16,569 23,687 10,971 19,914 8,463 9,662 0.0 0.0     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   15,914 12,802 12,531 12,152 12,992 14,882 0.0 0.0   Gross profit growth   -4.2% -19.6% -2.1% -3.0% 6.9% 14.5% -100.0% 0.0%   Employees   8 8 8 8 9 9 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 12.5% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   56,900 49,896 48,796 47,451 37,935 34,198 0 0   Balance sheet change%   11.7% -12.3% -2.2% -2.8% -20.1% -9.9% -100.0% 0.0%   Added value   10,248.3 7,280.6 6,851.6 6,486.4 6,530.5 7,937.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -12,229 -8,557 -8,169 -8,659 -9,259 -8,394 -16,135 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   4.2% 3.7% 5.3% 4.7% 4.7% 2.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   1.3% 1.2% 1.3% 1.2% 1.3% 1.1% 0.0% 0.0%   ROI %   1.6% 1.4% 1.5% 1.5% 1.5% 1.3% 0.0% 0.0%   ROE %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   161.7% 325.3% 160.1% 307.0% 129.7% 121.7% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.5% 2.4% 2.6% 2.6% 2.5% 2.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.5 3.2 2.5 3.0 2.5 2.9 0.0 0.0   Current Ratio   2.5 3.3 2.5 3.0 2.5 2.9 0.0 0.0   Cash and cash equivalent   11,071.0 2,235.8 13,202.2 2,476.2 12,110.2 9,059.8 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   18,094.4 16,971.0 14,384.4 16,986.9 11,966.5 11,159.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   1,281 910 856 811 726 882 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   1,281 910 856 811 725 882 0 0   EBIT / employee   84 60 84 71 68 40 0 0   Net earnings / employee   0 0 0 0 0 0 0 0